Anavex Life Sciences
AVXL
#8234
Rank
A$0.39 B
Marketcap
A$4.22
Share price
3.06%
Change (1 day)
-64.14%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -A$73.29 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$71.76 Million a decrease over its 2023 earnings that were of -A$62.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.29 Million2.14%
2024 -A$71.76 Million14.77%
2023 -A$62.53 Million-17.49%
2022 -A$75.78 Million22.96%
2021 -A$61.63 Million35.36%
2020 -A$45.53 Million12.65%
2019 -A$40.42 Million29.09%
2018 -A$31.31 Million36.33%
2017 -A$22.97 Million17.11%
2016 -A$19.61 Million20.91%
2015 -A$16.22 Million-6.29%
2014 -A$17.31 Million337.28%
2013 -A$3.96 Million
2008 -A$7.32 Million106.01%
2007 -A$3.56 Million8848.98%
2006 -A$0.04 Million-79.99%
2005 -A$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.22 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$10.08 M-115.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.68 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.37 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA